The abstract is read at the publisher; the summary is JClub's.
SPECTRA, a microbiome-informed multi-output random forest, discriminates 12 and 9 chronic-disease phenotypes with mean one-versus-rest AUCs of 0.92 (internal) and 0.79 (external) using gut microbiome indices.
- Why it matters: Chronic disease differentiation is still difficult in precision medicine, and although gut microbiomes contain disease-linked signatures, clinical use has been limited by how to summarize complex variation into actionable features.
- What they did: The study builds microbial representation indices (MRIs) that aggregate microbiome variation into phenotype-associated features, then trains SPECTRA to output risks for multiple diseases simultaneously.
- The result: SPECTRA captures shared biological features and generalizes to previously unseen diseases, and when integrated into xMICARE it yields interpretable, ranked, non-invasive risk profiles for individual samples.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.